Provided by Tiger Fintech (Singapore) Pte. Ltd.

Roivant Sciences Ltd.

10.67
-0.0050-0.05%
Volume:640.23K
Turnover:6.81M
Market Cap:7.61B
PE:-68.51
High:10.77
Open:10.75
Low:10.58
Close:10.67
Loading ...

Arbutus Biopharma Q1 2025: Revenue Up 20% to $1.8M, Net Loss Widens to $24.5M, EPS at $(0.13)

Reuters
·
Yesterday

Vivek Ramaswamy, 10% Owner, Reports Disposal of Common Shares of Roivant Sciences Ltd

Reuters
·
09 May

Roivant Sciences Ltd. (ROIV): Among David Einhorn’s Stock Picks with Huge Upside Potential

Insider Monkey
·
02 May

Roivant Sciences Price Target Maintained With a $18.00/Share by HC Wainwright & Co.

Dow Jones
·
22 Apr

Immunovant Names New CEO, CFO

MT Newswires Live
·
21 Apr

BRIEF-Immunovant Announces Next Phase Of Growth With Roivant Including Changes To Its Leadership Team And Additional Indications

Reuters
·
21 Apr

Immunovant CEO Salzmann Retires; Roivant Exec Venker Takes the Helm

Dow Jones
·
21 Apr

Immunovant Inc - Tiago Girao Appointed as CFO of Immunovant

THOMSON REUTERS
·
21 Apr

Immunovant Inc - Ind Cleared for Imvt-1402 in Sjd, Study to Initiate Summer 2025

THOMSON REUTERS
·
21 Apr

Immunovant Inc - Current Cash Balance Provides Runway Through Graves’ Disease Readout in 2027

THOMSON REUTERS
·
21 Apr

Immunovant Announces Next Phase of Growth With Roivant Including Changes to Its Leadership Team and Additional Indications SjÖGren’s Disease (Sjd) and Cutaneous Lupus Erythematosus (Cle) for Imvt-1402

THOMSON REUTERS
·
21 Apr

Arbutus Biopharma Cuts Workforce by More Than Half, Hires New CFO in Exec Shuffle

Dow Jones
·
27 Mar

Is Roivant Sciences Ltd. (NASDAQ:ROIV) One of The Best Stocks to Buy According to Billionaire David Einhorn?

Insider Monkey
·
26 Mar

Immunovant Ditches Seeking FDA Approval For Batoclimab For Two Autoimmune Disorders Despite Positive Phase 3 Data

Benzinga
·
20 Mar

Roivant Sciences Ltd - Phase 3 Mg Study Meets Primary Endpoint With 5.6 Point Improvement

THOMSON REUTERS
·
19 Mar

Roivant Sciences Unit, Arbutus File Lawsuits Against Moderna for Alleged Patent Infringement

MT Newswires Live
·
03 Mar

Genevant: Seeking Monetary Relief, Injunctions Against Spikevax &, Where Applicable, Additional Products That Moderna Represented Use Same Lnp Tech

THOMSON REUTERS
·
03 Mar

Genevant Sciences and Arbutus Biopharma Initiate International Patent Infringement Enforcement Actions Against Moderna

THOMSON REUTERS
·
03 Mar

Genevant Sciences and Arbutus Biopharma Initiate International Patent Infringement Enforcement Actions Against Moderna

GlobeNewswire
·
03 Mar

Early Warning Report Issued Pursuant to National Instrument 62‐103: Roivant Announces Resignation and Replacement of Arbutus Board

THOMSON REUTERS
·
25 Feb